{"id":"W2794417831","doi":"10.1002/cpt.1004","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Children's Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; Canada Foundation for Innovation; National Institute of Allergy and Infectious Diseases; Australian Centre for HIV and Hepatitis Virology Research","keywords":"Oxcarbazepine; Carbamazepine; Toxic epidermal necrolysis; Pharmacogenetics; Medicine; Genotype; Allele; Eosinophilia; Pharmacology; Guideline; Human leukocyte antigen; Epilepsy; Immunology; Dermatology; Genetics; Psychiatry; Biology; Pathology; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001295486,0.0002826013,0.0008129271,0.0001079726,0.0001371381,0.00001586918,0.0001236792,0.0003279745,0.00007299955],"category_scores_gemma":[0.0001254049,0.0002617376,0.0002173301,0.0001485865,0.001434814,0.0001113281,0.0001425691,0.0004689988,0.00001494932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003285733,"about_ca_system_score_gemma":0.0003028435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001353288,"about_ca_topic_score_gemma":0.00001548339,"domain_scores_codex":[0.996568,0.0003070196,0.001942254,0.0005932823,0.000173233,0.0004162174],"domain_scores_gemma":[0.9965687,0.001253279,0.0006238024,0.0003382744,0.0008433523,0.0003725848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002535938,0.002122454,0.1417214,0.0002142436,0.00603738,0.00004101776,0.0002204832,0.000007264832,0.3388387,0.0001151832,0.1003748,0.4077711],"study_design_scores_gemma":[0.01284347,0.001206056,0.05746328,0.00002162562,0.005869805,0.00007487086,0.00007431907,0.003987157,0.01327439,0.0000976002,0.9047902,0.0002972566],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785134,0.001143691,0.002319529,0.01228607,0.003373118,0.001838343,0.0002903905,0.00008710201,0.0001483367],"genre_scores_gemma":[0.8432775,0.02123516,0.02596026,0.1055197,0.003412232,0.00005997454,0.0002339645,0.0001019019,0.0001993855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8044153,"threshold_uncertainty_score":0.9999835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1847197132860234,"score_gpt":0.5213460437019938,"score_spread":0.3366263304159705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}